Cargando…

Association Between First-Line Immune Checkpoint Inhibition and Survival for Medicare-Insured Patients With Advanced Non–Small Cell Lung Cancer

IMPORTANCE: Immunotherapy is now a cornerstone of treatment for advanced non–small cell lung cancer (NSCLC), but its uptake and effectiveness among older patients outside clinical trials remain poorly understood. OBJECTIVE: To understand treatment patterns and evaluate the overall survival associate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kehl, Kenneth L., Greenwald, Scott, Chamoun, Nassib G., Manberg, Paul J., Schrag, Deborah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140374/ https://www.ncbi.nlm.nih.gov/pubmed/34019086 http://dx.doi.org/10.1001/jamanetworkopen.2021.11113

Ejemplares similares

Covid-19 and excess mortality in medicare beneficiaries
por: Greenwald, Scott D., et al.
Publicado: (2022)

Hospitalization and Survival of Medicare Patients Treated With Carboplatin Plus Paclitaxel or Pemetrexed for Metastatic, Nonsquamous, Non–Small Cell Lung Cancer
por: Brooks, Gabriel A., et al.
Publicado: (2018)

Association of Health Insurance Literacy With Enrollment in Traditional Medicare, Medicare Advantage, and Plan Characteristics Within Medicare Advantage
por: Park, Sungchul, et al.
Publicado: (2022)

Comparison of Ambulatory Care Access and Quality for Beneficiaries With Disabilities Covered by Medicare Advantage vs Traditional Medicare Insurance
por: Johnston, Kenton J., et al.
Publicado: (2022)

Evaluation of Potentially Avoidable Acute Care Utilization Among Patients Insured by Medicare Advantage vs Traditional Medicare
por: Beckman, Adam L., et al.
Publicado: (2023)

Association of Oncologist Participation in Medicare’s Oncology Care Model With Patient Receipt of Novel Cancer Therapies
por: Manz, Christopher R., et al.
Publicado: (2022)

Elucidating the association between regional variation in diagnostic frequency with risk-adjusted mortality through analysis of claims data of medicare inpatients: a cross-sectional study
por: Li, Linyan, et al.
Publicado: (2021)

Correlation Between Surrogate End Points and Overall Survival in a Multi-institutional Clinicogenomic Cohort of Patients With Non–Small Cell Lung or Colorectal Cancer
por: Kehl, Kenneth L., et al.
Publicado: (2021)

Measuring the Scope of Prior Authorization Policies: Applying Private Insurer Rules to Medicare Part B
por: Schwartz, Aaron L., et al.
Publicado: (2021)

Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019
por: McCoy, Rozalina G., et al.
Publicado: (2021)

Patterns of care for older patients with stage IV non‐small cell lung cancer in the immunotherapy era
por: Kehl, Kenneth L., et al.
Publicado: (2020)

Geographical Variation in Health Spending Across the US Among Privately Insured Individuals and Enrollees in Medicaid and Medicare
por: Cooper, Zack, et al.
Publicado: (2022)

Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance
por: DiStefano, Michael J., et al.
Publicado: (2023)

Association of Medicaid Insurance With Survival Among Patients With Small Cell Lung Cancer
por: Pezzi, Todd A., et al.
Publicado: (2020)

Use of First-Line Immune Checkpoint Inhibitors and Association With Overall Survival Among Patients With Metastatic Melanoma in the Anti–PD-1 Era
por: Lamba, Nayan, et al.
Publicado: (2022)

Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers
por: Lin, Dora H., et al.
Publicado: (2018)

Trends in Use of Granulocyte Colony-Stimulating Factor Following Introduction of Biosimilars Among Adults With Cancer and Commercial or Medicare Insurance From 2014 to 2019
por: Wang, Ching-Yu, et al.
Publicado: (2021)

Socioeconomic factors and Medicare supplemental health insurance
por: Garfinkel, Steven A., et al.
Publicado: (1987)

Association Between Smoking History and Overall Survival in Patients Receiving Pembrolizumab for First-Line Treatment of Advanced Non–Small Cell Lung Cancer
por: Popat, Sanjay, et al.
Publicado: (2022)

Palliative radiation and fractionation in medicare patients with incurable non-small cell lung cancer
por: Lam, Miranda B., et al.
Publicado: (2018)

Comparison of Care Quality Metrics in 2-Sided Risk Medicare Advantage vs Fee-for-Service Medicare Programs
por: Cohen, Kenneth, et al.
Publicado: (2022)

Genetic analysis of DAF-18/PTEN missense mutants for the ability to maintain quiescence of the somatic gonad and germ line in Caenorhabditis elegans dauer larvae
por: Wittes, Julia, et al.
Publicado: (2022)

Characteristics of Physicians Excluded From US Medicare and State Public Insurance Programs for Fraud, Health Crimes, or Unlawful Prescribing of Controlled Substances
por: Chen, Alice, et al.
Publicado: (2018)

Comparison of the Pathway to Hospice Enrollment Between Medicare Advantage and Traditional Medicare
por: Ankuda, Claire K., et al.
Publicado: (2023)

Comparison of Low-Value Services Among Medicare Advantage and Traditional Medicare Beneficiaries
por: Boudreau, Emily, et al.
Publicado: (2022)

Association Between Medicare Policy Reforms and Changes in Hospitalized Medicare Beneficiaries' Severity of Illness
por: Sukul, Devraj, et al.
Publicado: (2019)

Quality of Home Health Agencies Serving Traditional Medicare vs Medicare Advantage Beneficiaries
por: Schwartz, Margot L., et al.
Publicado: (2019)

Comparison of the Quality of Hospitals That Admit Medicare Advantage Patients vs Traditional Medicare Patients
por: Meyers, David J., et al.
Publicado: (2020)

Trends in Use of Low-Value Care in Traditional Fee-for-Service Medicare and Medicare Advantage
por: Park, Sungchul, et al.
Publicado: (2021)

Evaluation of Spending Differences Between Beneficiaries in Medicare Advantage and the Medicare Shared Savings Program
por: Parikh, Ravi B., et al.
Publicado: (2022)

Postacute Care Services Use and Outcomes Among Traditional Medicare and Medicare Advantage Beneficiaries
por: Achola, Emma M., et al.
Publicado: (2023)

Role of Patient Sorting in Avoidable Hospital Stays in Medicare Advantage vs Traditional Medicare
por: Xu, Jianhui (Frank), et al.
Publicado: (2023)

Family and Friend Perceptions of Quality of End-of-Life Care in Medicare Advantage vs Traditional Medicare
por: Ankuda, Claire K., et al.
Publicado: (2020)

Comparison of Health Care Utilization by Medicare Advantage and Traditional Medicare Beneficiaries With Complex Care Needs
por: Drzayich Antol, Dana, et al.
Publicado: (2022)

Lack of survival advantage among re-resected elderly glioblastoma patients: a SEER-Medicare study
por: Goldman, Debra A, et al.
Publicado: (2020)

Insurance Trends for the Medicare Population, 1991-1999
por: Murray, Lauren A., et al.
Publicado: (2002)

Trends in Medicare Supplementary Insurance: 1992-96
por: Eppig, Franklin J., et al.
Publicado: (1997)

Medicare Influence on Private Insurance: Good or Ill?
por: Jones, Stanley B.
Publicado: (1996)

Savings estimate for a Medicare insured group
por: Birnbaum, Howard, et al.
Publicado: (1991)

Health Care Utilization and Spending in Medicare Advantage vs Traditional Medicare: A Difference-in-Differences Analysis
por: Schwartz, Aaron L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dmn88idaers49c7auouh09to4t